Animal Toxicology Testing Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product (Consumables (Reagents & Kits, Animal Models, Mice Models, Rat Models, Other Animal Models), and Instruments)), By Testing Type (Chronic Toxicity Testing, Sub-Chronic Toxicity Testing, Sub-Acute Toxicity Testing, and Acute Toxicity Testing), By Toxicity Endpoint (Immunotoxicity, Systemic Toxicity, Carcinogenicity, Genotoxicity, Developmental and Reproductive Toxicity (DART), and Other Toxicity Endpoints), By Testing Facility (Outsourced Testing Facility, and In-House Testing Facility), and Region Forecast 2024-2030

The animal toxicology testing market size was valued at US$ XX million in 2023 and is projected to reach US$ XX million by 2030, at a CAGR of XX% from 2024-2030. Moreover, the U.S. animal toxicology testing market is projected to grow significantly, reaching an estimated US$ XX million by 2032.

The market is fuelled by growing regulatory requirements for safety assessments and increasing emphasis on product safety in pharmaceuticals and chemicals. However, the ethical issues related to animal testing and the increasing preference for alternative methods are limiting the market growth. Opportunities come from advancements in vitro and computational testing technologies, which serve as alternatives and reduce dependence on animals without compromising regulatory compliance. In the future, the market will probably continue to retain a balance between the traditional and the innovative, humane alternatives to it.

Key Players

Key players in the animal toxicology testing market include Charles River Laboratories, Covance (Labcorp Drug Development), Envigo, Eurofins Scientific, Wuxi AppTec, MediWound, and Toxicology Excellence for Risk Assessment (TERA). Also, a comprehensive analysis of industry verticals and market participants that provides a clear overview of the competitive landscape in relation to the sectors served by the company’s products and services, market share, service offerings, financial reports, significant developments, market strategy, competitive position, and geographic reach

Key Takeaways

• The North American region is the largest market and growing at its highest
• Based on the Product Consumables segment holds a 62.7% market share
• Based on the Testing Type Chronic Toxicity Testing segment holds a 29.6% market share
• Based on the Toxicity Endpoint Immunotoxicity segment holds a 24.1% market share
• Based on the Testing Facility Outsourced Testing Facility segment holds a 56.3% market share

Facts & Figures

• As of January 2023, over 90% of pharmaceutical companies indicated that they utilize animal models in their preclinical toxicology studies.
• By March 2024, around 50% of cosmetics brands in the U.S. had eliminated animal testing from their product development processes.
• By February 2024, around 65% of toxicology professionals believed that advancements in computational modeling could replace traditional animal testing in the next decade.

Key Developments

• In August 2022: Covance (Labcorp Drug Development) launched a new suite of regulatory-compliant toxicology services designed to meet evolving global standards
• In January 2023: Envigo introduced advanced animal welfare practices in toxicology studies, reflecting a commitment to ethical testing methods.
• In November 2024: Toxicology Excellence for Risk Assessment (TERA) will likely publish a follow-up report discussing the progress and future of alternative toxicology testing methods.

Animal Toxicology Testing Market Segmentation

By Product Type: The consumables segment is the leader in the market mainly because of the high demand for reagents and kits, which are highly consumed in different processes. Animal models in this respect mostly feature mice and rat models due to their usage on a very large scale.

By Testing Type: Based on the type of testing, the market is divided into chronic toxicity testing, sub-chronic toxicity testing, sub-acute toxicity testing, and acute toxicity testing. The chronic toxicity testing segment is often the market leader, aided by an important role in assessing the long-term effects of substances, especially in pharmaceuticals and chemicals. Such testing is essential for obtaining regulatory approval and generally receives more attention as sectors move from limited exposure to long-term security.

By Toxicity Endpoint: Based on toxic endpoints as the segmentation factor, the market of animal toxicology testing is classified into immunotoxicity, systemic toxicity, carcinogenicity, genotoxicity, developmental and reproductive toxicity (DART), and other toxicity endpoints. The systemic toxicity segment will generally capture the greatest share in the market because systemic toxicity can embrace a vast array of impacts on most organ systems in the body, representing one of the most crucial ways to measure the safety of substances in general. Immunotoxicity and carcinogenicity segments are equally important and need to be carried out with emphasis due to their paramount importance in the process of developing pharmaceutical products.

By Testing Facility: Based on testing facilities, animal toxicology testing has the following market segmentation outsourced testing facilities and in-house testing facilities. The outsourcing testing facility segment would hold the majority of the share primarily because most companies often engage with specialized laboratories characterized by expertise, advanced technological approaches, and compliance according to regulatory standards.